Lawmakers urge health industry players to work together on lowering drug prices

Members of the House Energy and Commerce Subcommittee on Health on Wednesday called on health care industry officials to set aside their differences and reach an agreement on reforms to the drug delivery system that could lower costs for consumers.

Members of the House Energy and Commerce Subcommittee on Health on Wednesday called on health care industry officials to set aside their differences and reach an agreement on reforms to the drug delivery system that could lower costs for consumers. The committee held a hearing focusing on the drug delivery system, during which various trade groups that represent drugmakers, PBMs, and health insurers blamed each other for rising drug prices. "You may have solutions that you can arrive at, not necessarily individually, but in collaboration," subcommittee Chairman Rep. Michael Burgess (R-TX) said at the hearing. "Those solutions may well be better than anything we or a federal agency can impose. But I guess the other side of that is, if we’re not moving toward some solution to this problem then there likely will be some type of action." Rep. Morgan Griffith (R-VA) warned that if the industries are not able to agree on reforms to the current drug supply system, Congress could be resigned to act with or without their consultation. Rep. Greg Walden (R-OR), who chairs the full committee, said he plans to have the committee continue discussion on the issue early next year.